Home
>
US Stocks
>
CorMedix Inc
CorMedix Inc
CRMD

CorMedix Inc (CRMD)

$4.7521.49%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.76
Today Low/High
4.71 / 4.86
52 Week Low/High
$3.86 / $18.8
Market Cap
$234.61M

Company Details

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath™, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. Defencath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product, which provides an additional five years of marketing exclusivity, which will be added to the five years granted to a New Chemical Entity upon approval of the NDA. CorMedix also intends to develop Defencath as a catheter lock solution for use in oncology and total parenteral nutrition patients. It is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with programs in surgical sutures and meshes, and topical hydrogels. The Company is also working with top-tier researchers to develop taurolidine-based therapies for rare pediatric cancers. Neutrolin™ is CE Marked and marketed in Europe and other territories as a medical device.
Organisation
CorMedix Inc
Headquaters
Berkeley Heights, New Jersey, US
Employees
35
Industry
Health Technology
CEO
Khoso Baluch

Discover more

Frequently Asked Questions

What is CorMedix Inc (CRMD) share price today?

Can Indians buy CorMedix Inc (CRMD) shares?

How can I buy CorMedix Inc (CRMD) shares from India?

Can Fractional shares of CorMedix Inc (CRMD) be purchased?

What are the documents required to start investing in CorMedix Inc (CRMD) stocks?

We are a SEBI registered investement advisor